Back
BioXcel Therapeutics Stock Price Chart
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
19
BTAI
BioXcel Therapeutics
Last Price:
$1.64
Seasonality Move:
-21.52%
7 Day Trial
ALL ACCESS PASS
$
7
Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
The current trend is relatively stagnant and BTAI is experiencing selling pressure, which indicates risk of future bearish movement.
BioXcel Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.72 | Sell |
| 20-day SMA: | 1.56 | Buy |
| 50-day SMA: | 1.62 | Sell |
| 200-day SMA: | 5.19 | Sell |
| 8-day EMA: | 1.67 | Sell |
| 20-day EMA: | 1.62 | Sell |
| 50-day EMA: | 1.79 | Sell |
| 200-day EMA: | 9.72 | Sell |
BioXcel Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 49.03 | Sell |
| Chaikin Money Flow: | -138939 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.31 - 1.75) | Buy |
| Bollinger Bands (100): | (1.23 - 3.09) | Sell |
BioXcel Therapeutics Technical Analysis
| Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioXcel Therapeutics Stock
Is BioXcel Therapeutics Stock a Buy?
-
BioXcel Therapeutics share price is 1.60 while BTAI 8-day simple moving average is 1.72, which is a Sell signal.
-
The stock price of BTAI is 1.60 while BioXcel Therapeutics 20-day SMA is 1.56, which makes it a Buy.
-
BioXcel Therapeutics 50-day simple moving average is 1.62 while BTAI share price is 1.60, making it a Sell technically.
-
BTAI stock price is 1.60 and BioXcel Therapeutics 200-day simple moving average is 5.19, creating a Sell signal.
BTAI Technical Analysis vs Fundamental Analysis
Sell
19
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy or a Sell?
-
BioXcel Therapeutics stock is rated a SellThe current BioXcel Therapeutics [BTAI] share price is $1.60. The Score for BTAI is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
BioXcel Therapeutics Stock Info
Market Cap:
9.7M
Price in USD:
1.60
Share Volume:
138.9K
BioXcel Therapeutics 52-Week Range
52-Week High:
25.12
52-Week Low:
1.17
Sell
19
BioXcel Therapeutics (BTAI)
is a Sell
BioXcel Therapeutics Share Price Forecast
-
What is the BioXcel Therapeutics stock price today?The BioXcel Therapeutics stock price is 1.60 USD today.
-
Will BTAI stock go up or go down?BioXcel Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is BioXcel Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioXcel Therapeutics is overvalued.
Is BioXcel Therapeutics Stock a Buy?
-
BioXcel Therapeutics share price is 1.60 while BTAI 8-day exponential moving average is 1.67, which is a Sell signal.
-
The stock price of BTAI is 1.60 while BioXcel Therapeutics 20-day EMA is 1.62, which makes it a Sell.
-
BioXcel Therapeutics 50-day exponential moving average is 1.79 while BTAI share price is 1.60, making it a Sell technically.
-
BTAI stock price is 1.60 and BioXcel Therapeutics 200-day simple moving average is 9.72, creating a Sell signal.
Fundamental Analysis of BioXcel Therapeutics
Is BioXcel Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $7.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $19.14 per share, and a decrease next year of $0.76 per share.
Technical Analysis of BioXcel Therapeutics
Should I short BioXcel Therapeutics stock?
-
BTAI Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting BioXcel Therapeutics is a Buy
-
BioXcel Therapeutics Relative Strength Index (RSI) is 49.03, which suggest BioXcel Therapeutics is oversold
-
The Bollinger Bands (25) for BioXcel Therapeutics is (1.31 - 1.75), which suggest BioXcel Therapeutics is a Sell
-
The Bollinger Bands (100) for BioXcel Therapeutics is (1.23 - 3.09), which suggest BioXcel Therapeutics is a Sell
* BioXcel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.